SCHEMBL8939126

SCHEMBL8939126

Cc1cc2c(=O)[nH]ccc2cc1OC1CCN(CC2CCCC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 7/20 0.60
MAP2K1 Q02750 3/20 0.43
ACHE P22303 4/20 0.42
HTR4 Q13639 4/20 0.42
ROCK2 O75116 2/20 0.40
PRKACA P17612 1/20 0.40
PRKCD Q05655 1/20 0.40
PRKG1 Q13976 1/20 0.40
PKN1 Q16512 1/20 0.40
PKN2 Q16513 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
CDC42BPA Q5VT25 1/20 0.40
Q6ZSR9 Q6ZSR9 1/20 0.40
BMP2K Q9NSY1 1/20 0.40
CDC42BPB Q9Y5S2 1/20 0.40
HRH1 P35367 3/20 0.40
CCR3 P51677 3/20 0.40
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938003 0.99 ROCK1 (0.59) ROCK1MAP2K1ACHEHTR4ROCK2
SCHEMBL8938029 0.96 ROCK1 (0.59) ROCK1MAP2K1ACHEHTR4ROCK2
SCHEMBL8937843 0.92 ROCK1 (0.60) ROCK1MAP2K1ROCK2PRKACAPRKCD
SCHEMBL8939175 0.89 ROCK1 (0.57) ROCK1MAP2K1ACHEHTR4ROCK2
SCHEMBL8937914 0.88 ROCK1 (0.64) ROCK1MAP2K1ROCK2PRKACAPRKCD
SCHEMBL8936423 0.88 ACHE (0.46) ROCK1MAP2K1ACHEHTR4ROCK2
SCHEMBL8937818 0.87 ROCK1 (0.52) ROCK1MAP2K1ROCK2PRKACAPRKCD
SCHEMBL8938080 0.87 ROCK1 (0.61) ROCK1MAP2K1ROCK2PRKACAPRKCD
SCHEMBL8934954 0.87 MAP2K1 (0.58) ROCK1MAP2K1ACHEHTR4ROCK2
SCHEMBL8938071 0.85 ROCK1 (0.59) ROCK1MAP2K1ROCK2PRKACAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188117-B2 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2012-05-29 US disclosed